Martek Biosciences Corp: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
345.20 Mil |
| Income |
40.59 Mil |
| Net Profit Margin |
11.76% |
| Return on Equity |
6.63% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
10.34 |
| Earnings/Share |
1.22 |
| Book Value/Share |
19.12 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (10/09) | FY (10/08) | FY (10/07) |
|---|
| 1st Qtr | 87.4 | 82.9 | 70.3 |
| 2nd Qtr | 92.4 | 90.7 | 76.7 |
| 3rd Qtr | 77.8 | 88.4 | 77.8 |
| 4th Qtr | 87.6 | 90.4 | 82.0 |
| Total | 345.2 | 352.4 | 306.8 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (10/09) | FY (10/08) | FY (10/07) |
|---|
| 1st Qtr | $0.29 | $0.26 | $0.09 |
| 2nd Qtr | $0.33 | $0.28 | $0.15 |
| 3rd Qtr | $0.27 | $0.28 | $0.19 |
| 4th Qtr | $0.33 | $0.32 | $0.56 |
| Total | $1.22 | $1.14 | $0.99 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (10/09) | FY (10/08) | FY (10/07) |
|---|
| 1st Qtr | -9% | -54% | --- |
| 2nd Qtr | 14% | 8% | 67% |
| 3rd Qtr | -18% | 0% | 27% |
| 4th Qtr | 22% | 14% | 195% |
| Yr. over Yr. EPS Growth Rate |
| FY (10/09) | FY (10/08) |
|---|
| 1st Qtr | 12% | 189% |
| 2nd Qtr | 18% | 87% |
| 3rd Qtr | -4% | 47% |
| 4th Qtr | 3% | -43% |
advertisement
Recent News